The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation?
International Journal of Molecular Sciences · 29.12.2023 · 25 (1) · 460
DOI: 10.3390/ijms25010460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.12.2023. Verfasst von Charlotte Klees und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory on Human Reproduction, Faculty of Medicine, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. Hauptthemen laut MEDLINE: MicroRNAs, Fertility Preservation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund for Scientific Research, Fonds Paul Genicot - Université Libre de Bruxelles, C.D.R.-F.N.R.S.
Abstract (Originalsprache)
Oncological treatments have dramatically improved over the last decade, and as a result, survival rates for cancer patients have also improved. Quality of life, including concerns about fertility, has become a major focus for both oncologists and patients. While oncologic treatments are often highly effective at suppressing neoplastic growth, they are frequently associated with severe gonadotoxicity, leading to infertility. For male patients, the therapeutic option to preserve fertility is semen cryopreservation. In prepubertal patients, immature testicular tissue can be sampled and stored to allow post-cure transplantation of the tissue, immature germ cells, or in vitro spermatogenesis. However, experimental techniques have not yet been proven effective for restoring sperm production for these patients. MicroRNAs (miRNAs) have emerged as promising molecular markers and therapeutic tools in various diseases. These small regulatory RNAs possess the unique characteristic of having multiple gene targets. MiRNA-based therapeutics can, therefore, be used to modulate the expression of different genes involved in signaling pathways dysregulated by changes in the physiological environment (disease, temperature, ex vivo culture, pharmacological agents). This review discusses the possible role of miRNA as an innovative treatment option in male fertility preservation–restoration strategies and describes the diverse applications where these new therapeutic tools could serve as fertility protection agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Laboratory on Human Reproduction, Faculty of Medicine, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
- Fertility Clinic, HUB-Erasme Hospital, 1070 Brussels, Belgium.
Förderung
- Fund for Scientific Research
- Fonds Paul Genicot - Université Libre de Bruxelles
- C.D.R.-F.N.R.S
- Paul Genicot Fund (Université libre de Bruxelles-Subsides 2020)
Zitieren
APA
Klees, C., Alexandri, C., Demeestere, I., & Lybaert, P. (2023). The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation?. International Journal of Molecular Sciences, 25(1), 460. https://doi.org/10.3390/ijms25010460
Vancouver
Klees C, Alexandri C, Demeestere I, Lybaert P. The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation?. International Journal of Molecular Sciences. 2023;25(1):460. doi:10.3390/ijms25010460
BibTeX
@article{Klees2023,
author = {Klees, Charlotte and Alexandri, Chrysanthi and Demeestere, Isabelle and Lybaert, Pascale},
title = {The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation?},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {25},
number = {1},
pages = {460},
doi = {10.3390/ijms25010460}
}
EUVIMED